Ophiopogonin D, a steroidal glycoside abrogates STAT3 signaling cascade and exhibits anti-cancer activity by causing GSH/GSSG imbalance in lung carcinoma

Ophiopogonin D, a steroidal glycoside abrogates STAT3 signaling cascade and exhibits anti-cancer activity by causing GSH/GSSG imbalance in lung carcinoma

10.3390/cancers10110427

Saved in:

書目詳細資料
Main Authors:	Lee, J.H, Kim, C, Lee, S.-G, Sethi, G, Ahn, K.S
其他作者:	PHARMACOLOGY
格式:	Article
出版:	2020
主題:	caspase glutathione glutathione disulfide glycoside ophiopogonin d STAT3 protein unclassified drug animal experiment animal model animal tissue antineoplastic activity apoptosis Article cancer inhibition controlled study drug effect drug inhibition drug mechanism enzyme activation female gene gene expression human human cell mouse non small cell lung cancer nonhuman oxidative stress signal transduction
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/177833
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	National University of Singapore

相似書籍

Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition
由: Mohan, P, et al.
出版: (2020)

Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance
由: Johansson, K., et al.
出版: (2014)

GSH, GSH-related enzymes and GS-X pump in relation to sensitivity of human tumor cell lines to chlorambucil and adriamycin
由: Zhang, K., et al.
出版: (2014)

Critical role of GSH in silica-induced oxidative stress, cytotoxicity, and genotoxicity in alveolar macrophages
由: Zhang, Z., et al.
出版: (2014)

Inhibition of glutathione reductase by plant polyphenols
由: Zhang, K., et al.
出版: (2014)

Glutathione-related mechanisms in cellular resistance to anticancer drugs (Review)
由: Zhang, K., et al.
出版: (2014)

Glutathione-related factors are not correlated with sensitivity of human tumour cells to actinomycin D
由: Zhang, K., et al.
出版: (2014)

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
由: Siveen, K.S, et al.
出版: (2020)

Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
由: Kaminska, K.K, et al.
出版: (2020)

Recombinant TSR1 of ADAMTS5 suppresses melanoma growth in mice via an anti-angiogenic mechanism
由: Renganathan, B, et al.
出版: (2020)

Inhibition of various isoforms of rat liver glutathione S-transferases by tannic acid and butein
由: Zhang, K., et al.
出版: (2014)

The role of resveratrol in cancer therapy
由: Ko, J.-H, et al.
出版: (2020)

Oxymatrine attenuates tumor growth and deactivates STAT5 signaling in a lung cancer xenograft model
由: Jung, Y.Y, et al.
出版: (2020)

DEVELOPMENT OF NANO-CELL VESICLE TECHNOLOGY SYSEM (nCVTs) FOR CANCER THERAPY
由: OU YI HSUAN
出版: (2021)

Navigating albumin-based nanoparticles through various drug delivery routes
由: Tan, YL, et al.
出版: (2022)

Targeting Polo-like Kinase 1 in Glioma Propagating Cells
由: FOONG SHU FEN CHARLENE
出版: (2012)

A study on the effects of glutathione (GSH) on the survival of UV-Irradiated Escherichia coli
由: Miranda, Ma.Tona R., et al.
出版: (1989)

FROM HIGH THROUGHPUT INHIBITOR DISCOVERY TO HIGHLY EFFICIENT CELLULAR DELIVERY OF THERAPEUTIC PROTEIN AND DRUG
由: FU JIAQI
出版: (2016)

A robust approach to enhance tumor-selective accumulation of nanoparticles
由: Qiao, Y, et al.
出版: (2020)

Silibinin down-regulates FAT10 and modulate TNF-α/IFN-ã-induced chromosomal instability and apoptosis sensitivity
由: Gao Y., et al.
出版: (2020)

Arsenic trioxide in ovarian cancer
由: ONG PEI SHI
出版: (2011)

PREDICTING CANCER DRUG RESPONSE USING A RECOMMENDER SYSTEM
由: CHAYAPORN SUPHAVILAI
出版: (2019)

The EMT spectrum and therapeutic opportunities
由: Voon, D.C, et al.
出版: (2020)

Inhibitory effects of plant polyphenols on rat liver glutathione S- transferases
由: Zhang, K., et al.
出版: (2013)

The effects of DLEU1 gene expression in Burkitt lymphoma (BL): Potential mechanism of chemoimmunotherapy resistance in BL
由: Lee, S, et al.
出版: (2020)

O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes
由: Kapoor R., et al.
出版: (2019)

A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
由: Dai X., et al.
出版: (2020)

Development of a novel small antibody that retains specificity for tumor targeting
由: Zhen, Z.-P, et al.
出版: (2020)

20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin
由: Kim, D.-G, et al.
出版: (2020)

Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
由: McCormack, W., et al.
出版: (2014)

Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4
由: Zhou, S., et al.
出版: (2014)

Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation
由: Chan, C.Y., et al.
出版: (2014)

?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
由: Siveen K.S., et al.
出版: (2020)

EFFECT OF OUABAIN ON THE DETACHMENT OF H23 LUNG CANCER CELL
由: Thidarat Ruanghirun
出版: (2014)

The investigational aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo
由: Zhou, N, et al.
出版: (2020)

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
由: Puppe, J, et al.
出版: (2020)

Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
由: Bhattacharya B., et al.
出版: (2020)

Biochemical and molecular characterisation of multidrug resistance protein 4 (MRP4)
由: BAI JING
出版: (2010)

Apoptotic cell death in disease—Current understanding of the NCCD 2023
由: Vitale, I, et al.
出版: (2023)

Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
由: Huynh, H, et al.
出版: (2020)